154 RELX Group Annual reports and financial statements 2015 Notes to the parent company financial statements 1 Investments Subsidiary Joint undertaking venture Total m m m At 1 January 2014 309 2,312 2,621 Equity instruments granted to employees of the Group 2 2 At 1 January 2015 309 2,314 2,623 Acquisitions 707 707 Disposal 232 232 Equity instruments granted to employees of the Group 2 2 At 31 December 2015 77 3,023 3,100 The joint venture is set out in note 3.
2 Related party transactions All transactions with joint ventures, subsidiaries and the Groups employees, which are related parties of RELX PLC, are reflected in these financial statements.
Transactions with key management personnel including share based remuneration costs are set out in note 28 of the Group consolidated financial statements and details of the directors remuneration are included in the Directors Remuneration Report on pages 77 to 90.
3 joint venture as at 31 December 2015 % holding as at 31 December RELX Group plc Incorporated and operating in Great Britain 1-3 Strand 63,226 ordinary voting shares 50% London WC2N 5JR 15,487 non-voting E shares During 2015 RELX Group plc was a holding company for group financing 21,287 non-voting R shares 100% activities and operating businesses involved in scientific and medical, risk Equivalent to a 52.9% equity interest and a and business analytics, legal markets and organisation of trade exhibitions 50% interest in the voting shares 4 Contingent liabilities There are contingent liabilities in respect of borrowings of joint ventures guaranteed by RELX PLC as follows: 2015 2014 m m Guaranteed jointly and severally with RELX NV 3,697 3,607 Financial instruments disclosures in respect of the borrowings covered by the above guarantees are given in note 19 of the Groups consolidated financial statements.
